AREPLIVIR (FAVIPIRAVIR) is a direct antiviral drug recommended by the Ministry of Health of the Russian Federation for the treatment of COVID-19 of any severity. FAVIPIRAVIR is an inhibitor of RNA-dependent-RNA polymerase (RdRp), an enzyme that is necessary for the reproduction of the virus.
Coronavir tablets p.p. 200mg 50pcs Antiviral agent
Rowcoxib-Rowtech (Celecoxib) 200mg 10 capsules Coxibes
Celebrex (Celecoxib) capsules Coxibes 100mg 10 capsules, 200mg 10 capsules, 200mg 30 capsules,
Dilaxa (Celecoxib) capsules Coxibes 100mg 10 capsules, 200mg 10 capsules, 200mg 30 capsules,
Cerebrovascular diseases: - acute disorders of cerebral circulation in the acute and early rehabilitation period of the course of the disease as part of complex therapy.